Depressive symptoms in acute schizophrenic inpatients
Rifkin, A.
Journal of Clinical Psychiatry 47(6): 329
1986
ISSN/ISBN: 0160-6689 PMID: 3711033 Document Number: 268754
Document emailed within 1 workday
Related Documents
Keller, R.; Rigardetto, R.; Vaccarino, P.; Maggioni, M.; Iannoccari, G.; Teriaca, M.J. 2008: Screening anxious-depressive symptoms and pain in medical inpatients Panminerva Medica 50(3): 217-220Bottlender, R.; Hampel, H.; Sievers, M.; Möller, H.J. 2005: Diagnostics and therapy of depressive symptoms in schizophrenic patients MMW Fortschritte der Medizin 147(Special Issue 2): 59-62
Svestka, J.; Náhunek, K. 1989: Therapeutic results in acute phases of manic depressive and schizophrenic psychoses as possible predictors of the prophylactic effect Activitas Nervosa Superior 31(1): 51-52
Koenig, H.G. 1991: Depressive disorders in older medical inpatients American Family Physician 44(4): 1243-1250
Laux, G.; Beckmann, H.; Classen, W.; Becker, T. 1989: Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder Journal of Neural Transmission. Supplementum 28: 45-52
Yorifuji, K.; Minami, K.; Yamada, Y.; Saito, Y.; Yagasaki, A.; Watanabe, A.; Wakabayashi, T.; Takahashi, K. 1980: Clinical data and brain atrophy--studies on computerized tomography of schizophrenic inpatients (2) Seishin Shinkeigaku Zasshi 82(3): 169-181
Eilenberg, D. 1980: A double-blind comparative trial of dothiepin and imipramine for the treatment of depressive inpatients New Zealand Medical Journal 91(653): 92-93
Hinterhuber, H.; Neumann, R. 1985: Depressive syndromes within the scope of schizophrenic psychoses Wiener Medizinische Wochenschrift 135(18): 435-441
Nagel, S.; Tegeler, J.; Goertz, B. 1982: Serum concentration of beta-endorphin in schizophrenic and depressive diseases Der Nervenarzt 53(11): 659-663
Fähndrich, E. 1982: Sleep deprivation therapy of depressive syndromes in schizophrenic disorders Der Nervenarzt 53(5): 279-293
Prilipko, L.L.; Erin, A.N.; Beliaev, B.S.; Piatnitskiĭ, A.N.; Siuniakov, S.A. 1987: Activation of lipid peroxidation in the bodies of schizophrenic and manic-depressive patients Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(1): 100-103
Young, R.C.; Nysewander, R.W.; Schreiber, M.T. 1983: Mania scale scores, signs, and symptoms in forty inpatients Journal of Clinical Psychiatry 44(3): 98-100
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Orsulak, P.J.; Schildkraut, J.J.; Schatzberg, A.F.; Herzog, J.M. 1978: Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders Biological Psychiatry 13(6): 637-647
Haase, H.J. 1979: Ambulatory continuing care of mental patients with manic depressive and schizophrenic psychoses Zfa. Zeitschrift für Allgemeinmedizin 55(16): 963-971
Lee, W.C. 1971: Understanding of symptoms of a schizophrenic patient Hu Li Za Zhi Journal of Nursing 18(2): 75-78
Craig, T.J.; van Natta, P.A. 1982: Medication use and depressive symptoms New York State Journal of Medicine 82(10): 1439-1443
Yorifuji, K.; Minami, K.; Yamada, Y.; Saito, Y.; Yagasaki, A.; Watanabe, A.; Wakabayashi, T.; Takahashi, K. 1980: Measurement of brain atrophy with computerized tomography--studies on computerized tomography of schizophrenic inpatients (1) Seishin Shinkeigaku Zasshi 82(3): 159-168
Griffin, S.J.; Friedman, M.J. 1986: Depressive symptoms in propranolol users Journal of Clinical Psychiatry 47(9): 453-457
Müller-Spahn, F.; Modell, S.; Thomma, M. 1992: New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms Der Nervenarzt 63(7): 383-400